Characteristics | No. of patients (%) |
---|---|
Total number | 42 (100%) |
Male/Female | 26/16 (61.9/38.1) |
Age (years) | |
median | 73 |
range | 70–81 |
Performance Status | |
ECOG 0 | 18 (42.8) |
ECOG 1 | 24 (57.2) |
Tumor differentiation | |
Well differentiated | 10 (23.8) |
Moderately differentiated | 13 (30.9) |
Poorly differentiated or undifferentiated | 19 (45.3) |
Locally advanced disease | 10 (23.8) |
Metastatic disease | 32 (76.2) |
Number of metastases | |
1 | 16 (38.2) |
2 | 19 (45.2) |
3+ | 7 (16.6) |
Sites of metastases | |
Liver | 20 (47.6) |
Peritoneum | 9 (21.4) |
Nodes | 22 (52.4) |
Local | 15 (35.7) |
Other | 6 (14.3) |
Prior adjuvant chemotherapy | |
None | 35 (83.3) |
Yes | 7 (16.7) |
Patients with metastases at the diagnosis | 18 (42.8) |
Number of cycles | |
Total | 540 |
Median | 12 |
Range | 3–24 |